Logo for the University of Illinois at Chicago
    • Login
    View Item 
    •   INDIGO Home
    • Medicine, College of
    • College of Medicine at Chicago
    • Cardiovascular Research, Center for
    • Publications - Cardiovascular Research
    • View Item
    •   INDIGO Home
    • Medicine, College of
    • College of Medicine at Chicago
    • Cardiovascular Research, Center for
    • Publications - Cardiovascular Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages

    Thumbnail
    View/Open
    Main Article (1.149Mb)
    Date
    2012-11
    Author
    Xiao, Lei
    Ornatowska, Magdalena
    Zhao, Guiqing
    Cao, Hongmei
    Yu, Rui
    Deng, Jing
    Li, Yongchao
    Zhao, Qiong
    Sadikot, Ruxana T.
    Christman, John W.
    Publisher
    Public Library of Science
    Metadata
    Show full item record
    Abstract
    Cyclooxygenase (COX)-2 expression and release of prostaglandins (PGs) by macrophages are consistent features of lipopolysaccharide (LPS)-induced macrophage inflammation. The two major PGs, PGE(2) and PGD(2), are synthesized by the prostanoid isomerases, PGE synthases (PGES) and PGD synthases (PGDS), respectively. Since the expression profile and the individual role of these prostanoid isomerases-mediated inflammation in macrophages has not been defined, we examined the LPS-stimulated PGs production pattern and the expression profile of their synthases in the primary cultured mouse bone marrow derived macrophages (BMDM). Our data show that LPS induced both PGE(2) and PGD(2) production, which was evident by ∼8 hrs and remained at a similar ratio (∼1∶1) in the early phase (≤12 hrs) of LPS treatment. However, PGE(2) production continued increase further in the late phase (16-24 hrs); whereas the production of PGD(2) remained at a stable level from 12 to 24 hrs post-treatment. In response to LPS-treatment, the expression of both COX-2 and inducible nitric oxide synthase (iNOS) was detected within 2 to 4 hrs; whereas the increased expression of microsomal PGES (mPGES)-1 and a myeloid cell transcription factor PU.1 did not appear until later phase (≥12 hrs). In contrast, the expression of COX-1, hematopoietic-PGDS (H-PGDS), cytosolic-PGES (c-PGES), or mPGES-2 in BMDM was not affected by LPS treatment. Selective inhibition of mPGES-1 with either siRNA or isoform-selective inhibitor CAY10526, but not mPGES-2, c-PGES or PU.1, attenuated LPS-induced burst of PGE(2) production indicating that mPGES-1 mediates LPS-induced PGE(2) production in BMDM. Interestingly, selective inhibition of mPGES-1 was also associated with a decrease in LPS-induced iNOS expression. In summary, our data show that mPGES-1, but not mPGES-2 or c-PGES isomerase, mediates LPS-induced late-phase burst of PGE(2) generation, and regulates LPS-induced iNOS expression in BMDM.
    Type
    Article
    Date available in INDIGO
    2013-11-26T21:35:45Z
    URI
    http://hdl.handle.net/10027/10678
    Collections
    • Publications - Cardiovascular Research
    • Publications - Medicinal Chemistry and Pharmacognosy

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV

    Browse

    All of INDIGOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV